I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nishiya, Yumi
30
results:
Search for persons
X
Format
Online (30)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (19)
Sorted by: Relevance
Sorted by: Year
?
1
Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conj..:
Suzuki, Hirokazu
;
Nagase, Shotaro
;
Saito, Chiemi
...
Molecular Cancer Therapeutics. 23 (2024) 3 - p. 257-271 , 2024
Link:
https://doi.org/10.1158/..
?
2
DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibo..:
Yamato, Michiko
;
Hasegawa, Jun
;
Maejima, Takanori
...
Molecular Cancer Therapeutics. 21 (2022) 4 - p. 635-646 , 2022
Link:
https://doi.org/10.1158/..
?
3
Estimation of fraction of drug metabolism by a single UDP‐g..:
Honda, Tomoyo
;
Obuchi, Wataru
;
Nishiya, Yumi
...
Biopharmaceutics & Drug Disposition. 43 (2022) 5 - p. 213-217 , 2022
Link:
https://doi.org/10.1002/..
?
4
Quizartinib, a selective FLT3 inhibitor, maintains antileuk..:
Aikawa, Tomoya
;
Togashi, Noriko
;
Iwanaga, Koichi
...
Oncotarget. 11 (2020) 11 - p. 943-955 , 2020
Link:
https://doi.org/10.18632..
?
5
Identification of non-P450 enzymes involved in the metaboli..:
Nishiya, Yumi
;
Suzuki, Eiko
;
Ishizuka, Tomoko
...
Drug Metabolism and Pharmacokinetics. 35 (2020) 1 - p. 45-55 , 2020
Link:
https://doi.org/10.1016/..
?
6
Effect of inter-individual variability in human liver cytoc..:
Kishino, Yuki
;
Hasegawa, Tomoko
;
Kato, Ayako
...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 838 (2019) - p. 37-45 , 2019
Link:
https://doi.org/10.1016/..
?
7
Bioactivation of loxoprofen to a pharmacologically active m..:
Sawamura, Ryoko
;
Sakurai, Hidetaka
;
Wada, Naoya
...
Biopharmaceutics & Drug Disposition. 36 (2015) 6 - p. 352-363 , 2015
Link:
https://doi.org/10.1002/..
?
8
Pharmacokinetics of DS-5565, a Novel α2δ Ligand, in Rats an..:
Yamamura, Naotoshi
;
Yamada, Makiko
;
Takahashi, Makoto
...
Neurology. 82 (2014) 10_supplement - p. , 2014
Link:
https://doi.org/10.1212/..
?
9
Comparison of Human Cytochrome P450 Inhibition by the Thien..:
Hagihara, Katsunobu
;
Nishiya, Yumi
;
Kurihara, Atsushi
...
Drug Metabolism and Pharmacokinetics. 23 (2008) 6 - p. 412-420 , 2008
Link:
https://doi.org/10.2133/..
?
10
Enantioselective 2‐hydroxylation of RS‐8359, a selective an..:
Itoh, Kunio
;
Nishiya, Yumi
;
Takasaki, Wataru
..
Chirality. 18 (2006) 8 - p. 592-598 , 2006
Link:
https://doi.org/10.1002/..
?
11
Figure S4 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:
Hirokazu Suzuki
;
Shotaro Nagase
;
Chiemi Saito
...
https://figshare.com/articles/figure/Figure_S4_from_Raludotatug_Deruxtecan_a_CDH6-Targeting_Antibody_Drug_Conjugate_with_a_DNA_Topoisomerase_I_Inhibitor_DXd_Is_Efficacious_in_Human_Ovarian_and_Kidney_Cancer_Models/25338019. , 2024
Link:
https://doi.org/10.1158/..
?
12
Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:
Hirokazu Suzuki
;
Shotaro Nagase
;
Chiemi Saito
...
doi:10.1158/1535-7163.25338007.v1. , 2024
Link:
https://doi.org/10.1158/..
?
13
Figure S2 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:
Hirokazu Suzuki
;
Shotaro Nagase
;
Chiemi Saito
...
doi:10.1158/1535-7163.25338025.v1. , 2024
Link:
https://doi.org/10.1158/..
?
14
Table S2 from Raludotatug Deruxtecan, a CDH6-Targeting Anti..:
Hirokazu Suzuki
;
Shotaro Nagase
;
Chiemi Saito
...
https://figshare.com/articles/journal_contribution/Table_S2_from_Raludotatug_Deruxtecan_a_CDH6-Targeting_Antibody_Drug_Conjugate_with_a_DNA_Topoisomerase_I_Inhibitor_DXd_Is_Efficacious_in_Human_Ovarian_and_Kidney_Cancer_Models/25338010. , 2024
Link:
https://doi.org/10.1158/..
?
15
Figure S3 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:
Hirokazu Suzuki
;
Shotaro Nagase
;
Chiemi Saito
...
doi:10.1158/1535-7163.25338022.v1. , 2024
Link:
https://doi.org/10.1158/..
1-15